𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Nicotine dependence treatment for patients with cancer : Review and recommendations

✍ Scribed by Lisa Sanderson Cox; Nicole L. Africano; Kenneth P. Tercyak; Kathryn L. Taylor


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
119 KB
Volume
98
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Cancer patients who use tobacco demonstrate characteristics of strong nicotine dependence and are at increased risk for future tobacco‐related morbidity and mortality. Continued smoking may contribute to poorer cancer treatment outcome and additional illness. In contrast, stopping smoking may improve quality of life and facilitate cancer treatment. Unfortunately, limited attention has been given to addressing tobacco use and treating nicotine dependence in cancer patients.

METHODS

The authors reviewed the current literature on smoking cessation and nicotine dependence treatment in patients with cancer.

RESULTS

Nicotine dependence treatment in patients with cancer facilitates smoking cessation. Evidence that cancer patients are motivated and able to stop smoking support tobacco use treatment intervention. Research is needed to evaluate effective intervention to aid tobacco abstinence and evaluate related health benefits for this patient population.

CONCLUSIONS

Cancer patients are able to stop smoking and benefit from intervention. Treatment of nicotine dependence in cancer patients merits attention from researchers and healthcare providers. The health risks of continued smoking and clear benefits of tobacco abstinence provide an ethical imperative for treating nicotine dependence in cancer patients. Research is needed to evaluate effective intervention with the overall goal of promoting tobacco abstinence to benefit oncology treatment and patient health. Cancer 2003;98:632–44. Β© 2003 American Cancer Society.

DOI 10.1002/cncr.11538


πŸ“œ SIMILAR VOLUMES


Evidence-based review of treatment optio
✍ Dana M. Hartl; Alfio Ferlito; Daniel F. Brasnu; Johannes A. Langendijk; Alessand πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 136 KB πŸ‘ 1 views

## Abstract Evidence‐based medicine integrates the best available data in decision making, with the goal of minimizing physicians' and patients' subjectivity. In 2006, the American Society of Clinical Oncology edited clinical practice guidelines for the use of larynx preservation strategies. The ob

Reboxetine for the treatment of patients
✍ N. Szerman; L. Peris; B. MesΓ­as; P. Colis; J. Rosa; A. Prieto πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 55 KB πŸ‘ 1 views

Background Although several approaches have been attempted for cocaine dependence, the pharmacological treatment of this serious disorder remains unclear. To date, desipramine, a tricyclic antidepressant of great noradrenergic activity, has shown the best results. Reboxetine, a selective noradrenali

Anticoagulation for the initial treatmen
✍ Elie A. Akl; Sandeep Rohilla; Maddalena Barba; Francesca Sperati; Irene Terrenat πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 312 KB πŸ‘ 1 views

## Abstract ## BACKGROUND. The authors compared the relative efficacy and safety of low‐ molecular‐weight heparin (LMWH) and unfractionated heparin (UFH) for the initial treatment of venous thromboembolism (VTE) between patients with and without cancer. ## METHODS. By using Cochrane methodology

Tobacco use outcomes among patients with
✍ Yolanda I. Garces; Darrell R. Schroeder; Liza M. Nirelli; Gary A. Croghan; Ivana πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 110 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The current study described tobacco use outcomes among patients with head and neck carcinoma who underwent treatment for nicotine dependence at the Mayo Clinic Nicotine Dependence Center (NDC; Rochester, MN). ## METHODS Using a 1:1 matched‐pair design, conditional logis